Details for New Drug Application (NDA): 073249
✉ Email this page to a colleague
NDA 073249 describes GYNIX, which is a drug marketed by Teva Pharms and is included in one NDA. Additional details are available on the GYNIX profile page.
The generic ingredient in GYNIX is clotrimazole. There are eleven drug master file entries for this compound. Twenty-eight suppliers are listed for this compound. Additional details are available on the clotrimazole profile page.
The generic ingredient in GYNIX is clotrimazole. There are eleven drug master file entries for this compound. Twenty-eight suppliers are listed for this compound. Additional details are available on the clotrimazole profile page.
Summary for 073249
| Tradename: | GYNIX |
| Applicant: | Teva Pharms |
| Ingredient: | clotrimazole |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 073249
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;VAGINAL | Strength | 100MG | ||||
| Approval Date: | Feb 13, 1998 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
